Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 13.55 is 28% below its 5-year average of 18.72, near the low end of its 5-year range (3.63–48.96).
As of the fiscal period ended Tuesday, June 30, 2026. 5.10% below its 12-month average of 14.28.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.55.
CURRENT RATIO
13.55
CURRENT RATIO AVG TTM
14.28
CURRENT RATIO AVG 3Y
15.97
CURRENT RATIO AVG 5Y
18.72
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.10%
CURRENT VS 3Y AVG
-15.14%
CURRENT VS 5Y AVG
-27.62%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+260.46%
vs the sector median at left
LENZ Therapeutics, Inc.
Market Cap
$118.83M
Current Ratio
13.55
TTM Avg
14.28
3Y Avg
15.97
5Y Avg
18.72
Market Cap
$118.59M
Current Ratio
4.52
TTM Avg
5.53
3Y Avg
5.99
5Y Avg
10.25
Market Cap
$117.76M
Current Ratio
9.23
TTM Avg
4.04
3Y Avg
4.74
5Y Avg
7.63
Market Cap
$120.58M
Current Ratio
10.21
TTM Avg
11.59
3Y Avg
10.00
5Y Avg
8.96
Market Cap
$115.67M
Current Ratio
3.36
TTM Avg
3.23
3Y Avg
4.24
5Y Avg
6.08
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. (LENZ) | $118.83M | 13.55 | 14.28 | 15.97 | 18.72 |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $118.59M | 4.52 | 5.53 | 5.99 | 10.25 |
| Cibus, Inc. (CBUS)vs › | $119.84M | 1.62 | 0.78 | 1.43 | 2.42 |
| Spruce Biosciences, Inc. (SPRB)vs › | $117.76M | 9.23 | 4.04 | 4.74 | 7.63 |
| Seer, Inc. (SEER)vs › | $120.41M | 14.74 | 14.69 | 22.23 | 28.85 |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | 10.21 | 11.59 | 10.00 | 8.96 |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | 12.26 | 9.59 | 11.55 | 11.23 |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | 3.36 | 3.23 | 4.24 | 6.08 |
| BGM Group Ltd. (BGM)vs › | $122.43M | 1.25 | 2.31 | 3.27 | 2.89 |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | 6.61 | 6.96 | 5.91 | 6.89 |
Current Ratio
13.55
Quick Ratio
13.31
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 13.55 |
| 2026-03-31 | 10.40 |
| 2025-12-31 | 14.23 |
| 2025-09-30 | 12.69 |
| 2025-06-30 | 20.54 |
| 2025-03-31 | 23.09 |
| 2024-12-31 | 20.36 |
| 2024-09-30 | 28.63 |
| 2024-06-30 | 23.23 |
| 2024-03-31 | 11.47 |
| 2023-12-31 | 3.63 |
| 2023-09-30 | 5.34 |
| 2023-06-30 | 20.47 |
| 2023-03-31 | 18.85 |
| 2022-12-31 | 4.91 |
| 2022-09-30 | 22.07 |
| 2022-06-30 | 27.07 |
| 2022-03-31 | 26.93 |
| 2021-12-31 | 31.44 |
| 2021-09-30 | 35.60 |
| 2021-06-30 | 48.96 |
| 2021-03-31 | 28.20 |
| 2020-12-31 | 0.66 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
